Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-3357 in patients with disseminated intravascular coagulation (JAAM-defined DIC)
jRCT2080221497Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of antithrombin alfa in disseminated intravascular coagulation (DIC), sponsored by Kyowa Kirin.
02
Drugs
antithrombin alfa
03
Conditions
disseminated intravascular coagulation (DIC)
Beyond the preview
Go deeper on jRCT2080221497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221497.